Blog - Pharmacogenetics, or the study of how people respond differently to medicines due to their genetics, is making a splash lately thanks to companies like Minneapolis, MN-based OneOme, which co-developed its RightMed test with Mayo Clinic
11 July 2018News - Distribution agreement to supply range of state-of-the-art sonication systems for DNA fragmentation
16 November 2017News - Funding to develop liver targeted gene activation therapies
02 November 2017News - Money will support the manufacture of future medicines through better measurement
08 January 2018Blog - Researchers at the New York Presbyterian Hospital (NYPH) and Weill Cornell Medical Center (WCMC) presented a poster on the validation of an Oncomine™ cell-free DNA Lung Assay using ctDNA NGS standards developed by SeraCare
22 February 2019Blog - The team at SeraCare have been experiencing the sights and sounds of the annual AACR meeting this week in Atlanta, and they are exciting about what they're learning! Catherine Huang, Director of Product Development at SeraCare, shared her top highlights from Atlanta this week
05 April 2019Blog - SeraCare recently hosted a dinner seminar to discuss the very topic of how clinical labs with liquid biopsy assays can better support the development of clinical validation of liquid biopsies and then clinical utility in patient care.
23 April 2019News - Nexar workflow continues to enable simple, scalable, and cost-effective testing
29 October 2021News - The exclusive partnership will also be extended to include the analysis of phenotypic-genotypic correlations and metabolic profiling of some common maternal/ fetal cardiac defects known to be related to monogenic disorders.
02 August 2022